Form D · Other Health Care

BioSig Technologies, Inc.

Los Angeles, CA · CIK 0001530766

Offering snapshot reported Mar 26, 2025 · SEC filing

Reported sold
$819K
Offering amount: $819K
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 5, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 26, 2025Initial$818,998No comparison11SEC filing
Jun 6, 2024Initial$3,000,005No comparison4SEC filing
Jun 6, 2024Initial$1,144,164No comparison6SEC filing
Jan 16, 2024Initial$1,478,526No comparison7SEC filing
Oct 25, 2023Initial$860,933No comparison20SEC filing
Oct 6, 2023Initial$1,169,715No comparison10SEC filing
Sep 27, 2023Initial$794,032No comparison4SEC filing
Aug 1, 2023Initial$2,204,136No comparison1SEC filing
May 26, 2023Initial$3,694,920No comparison20SEC filing
Apr 28, 2023Initial$1,392,738No comparison14SEC filing
Apr 5, 2023Initial$1,497,611No comparison5SEC filing
Mar 20, 2023Initial$2,531,520No comparison17SEC filing
Feb 14, 2023Initial$603,045No comparison5SEC filing
Feb 13, 2023Amendment$1,814,254$0vs Jan 17, 202317SEC filing
Feb 13, 2023Initial$2,000,750No comparison7SEC filing
Jan 31, 2023Initial$233,846No comparison3SEC filing
Jan 31, 2023Initial$1,897,955No comparison1SEC filing
Jan 17, 2023Initial$1,814,254No comparison17SEC filing
Jan 4, 2023Initial$1,098,092No comparison8SEC filing
Dec 30, 2022Amendment$1,452,000$0vs Nov 29, 202210SEC filing
Nov 29, 2022Initial$1,452,000No comparison10SEC filing
Jul 9, 2021Initial$600,000No comparison1SEC filing
May 5, 2020Initial$600,000No comparison1SEC filing
Nov 5, 2019Initial$686,370No comparison8SEC filing
Sep 9, 2019Initial$160,000No comparison1SEC filing
Aug 20, 2019Initial$3,260,000No comparison17SEC filing
Mar 28, 2019Initial$8,620,506No comparison103SEC filing
Aug 28, 2018Initial$4,071,189No comparison72SEC filing
Feb 27, 2018Initial$1,500,000No comparison2SEC filing
Nov 17, 2017Initial$2,000,000No comparison2SEC filing
Jul 20, 2017Initial$1,640,398No comparison22SEC filing
Mar 30, 2017Initial$0No comparison1SEC filing
Oct 31, 2016Initial$519,850No comparison4SEC filing
Nov 23, 2015Initial$1,020,000No comparison14SEC filing
May 19, 2015Initial$450,000No comparison2SEC filing
Apr 3, 2015Amendment$4,009,000$1,025,900vs Mar 10, 2015107SEC filing
Mar 10, 2015Amendment$2,983,100$557,500vs Feb 18, 201575SEC filing
Feb 18, 2015Amendment$2,425,600$842,500vs Jan 30, 201562SEC filing
Jan 30, 2015Amendment$1,583,100$1,071,000vs Dec 31, 201440SEC filing
Dec 31, 2014Initial$512,100No comparison24SEC filing
Sep 25, 2014Amendment$953,000$390,000vs Aug 22, 201423SEC filing
Aug 22, 2014Initial$563,000No comparison13SEC filing
May 6, 2014Amendment$574,400$369,500vs Apr 17, 201428SEC filing
Apr 17, 2014Initial$204,900No comparison6SEC filing
Feb 10, 2014Amendment$791,885$263,885vs Jan 13, 201416SEC filing
Jan 13, 2014Initial$528,000No comparison2SEC filing
Jul 26, 2013Amendment$2,781,000$359,000vs May 21, 201341SEC filing
May 21, 2013Amendment$2,422,000$187,000vs Mar 13, 201328SEC filing
Mar 13, 2013Amendment$2,235,000$415,000vs Feb 25, 201324SEC filing
Feb 25, 2013Initial$1,820,000No comparison16SEC filing
May 15, 2012Initial$887,500No comparison24SEC filing
Sep 23, 2011Amendment$922,000$0vs Sep 22, 201120SEC filing
Sep 22, 2011Initial$922,000No comparison20SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-542237
The Issuer sold an aggregate of 758,514 shares of the Company's common stock at a purchase price of $1.07974 per share and warrants to purchase up to 758,514 shares of common stock at an exercise price of $0.95474 per share.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Mar 26, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven E. Abelman Director
Anthony Amato Director, Executive
Chris Baer Director
James J. Barry Director
Donald F. Browne Director
Steven J Buhaly Executive
Gregory Cash Executive
Steve Chaussy Executive
Budimir S Drakulic Director, Executive
Andrew Filler Director
Seth Fischer Director
Michael Graydon Fleming, Jr. Executive
Donald E. Foley Director
David Foley Director
Patrick J. Gallagher Director
Ferdinand Groenewald Executive
Asher Holzer Director
Frederick D. Hrkac Director
James L. Klein Director
Kenneth L. Londoner Director, Executive
Lora Mikolaitis Executive
Samuel Navarro Director
Jeffrey O'donnell Director
Jeffrey O Donnell Director
Martha Pease Director
Kalyanam Shivkumar Director
John Sieckhaus Executive
Jonathan Steinhouse Director
Roy Tanaka Director
Bill Uglow Director
William Uglow Director
David Weild Director
David Weild Iv Director
Jerome Zeldis Director
Anthony Zook Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
12424 Wilshire Blvd Suite 745
Los Angeles, CA, 90025